Bisphosphonic acids and related compounds as inhibitors of nucleotide- and polyphosphate-processing enzymes: A PPK1 and PPK2 case study
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
Yn: Chemical biology & drug design, Cyfrol 93, Rhif 6, 01.06.2019, t. 1197-1206.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
APA
CBE
MLA
VancouverVancouver
Author
RIS
TY - JOUR
T1 - Bisphosphonic acids and related compounds as inhibitors of nucleotide- and polyphosphate-processing enzymes
T2 - A PPK1 and PPK2 case study
AU - Burda-Grabowska, Małgorzata
AU - Macegoniuk, Katarzyna
AU - Flick, Robert
AU - Nocek, Boguslaw P
AU - Joachimiak, Andrzej
AU - Yakunin, Alexander F
AU - Mucha, Artur
AU - Berlicki, Łukasz
N1 - © 2018 John Wiley & Sons A/S.
PY - 2019/6/1
Y1 - 2019/6/1
N2 - Bisphosphonic acids, which are structural analogs of pyrophosphate, constitute a class of compounds with very high potential for the construction of effective inhibitors of enzymes operating on oligo- and polyphosphates. The bisphosphonate-based methodology was applied for the discovery of inhibitors of two families of polyphosphate kinases (PPK1 and PPK2). Screening of thirty-two structurally diverse bisphosphonic acids and related compounds revealed several micromolar inhibitors of both enzymes. Importantly, selectivity of bisphosphonates could be achieved by application of the appropriate side chain.
AB - Bisphosphonic acids, which are structural analogs of pyrophosphate, constitute a class of compounds with very high potential for the construction of effective inhibitors of enzymes operating on oligo- and polyphosphates. The bisphosphonate-based methodology was applied for the discovery of inhibitors of two families of polyphosphate kinases (PPK1 and PPK2). Screening of thirty-two structurally diverse bisphosphonic acids and related compounds revealed several micromolar inhibitors of both enzymes. Importantly, selectivity of bisphosphonates could be achieved by application of the appropriate side chain.
KW - Diphosphonates/pharmacology
KW - Enzyme Inhibitors/pharmacology
KW - Isoenzymes/antagonists & inhibitors
KW - Nucleotides/metabolism
KW - Phosphotransferases (Phosphate Group Acceptor)/antagonists & inhibitors
KW - Polyphosphates/metabolism
U2 - 10.1111/cbdd.13439
DO - 10.1111/cbdd.13439
M3 - Article
C2 - 30484959
VL - 93
SP - 1197
EP - 1206
JO - Chemical biology & drug design
JF - Chemical biology & drug design
SN - 1747-0277
IS - 6
ER -